merck germany - Search News

News

Merck, SpringWorks

Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion

Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 billion, a deal that could give it access to a recently approved rare disease drug and expand its portfolio of experimental cancer treatments.

The Wall Street Journal on MSN · 1d

Germany’s Merck Nears Roughly $3.5 Billion Deal for SpringWorks

Germany’s Merck KGaA is finally nearing a roughly $3.5 billion deal for SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer, according to people familiar with the matter.

MarketWatch · 1d

SpringWorks Therapeutics Shares Rise Following WSJ Report of Merck KGaA Deal

Shares of SpringWorks Therapeutics climbed after The Wall Street Journal reported that Germany's Merck KGaA is nearing a $3.5 billion deal for the U.S. biopharmaceutical company. SpringWorks stock rose 8.7%, to $44.80, in afternoon trading Thursday. Shares are up 2.3% in the past year.

Merck, Current US Tariffs

Reuters on MSN · 1d

Merck posts higher profit, puts tariffs cost at $200 million

Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, reflecting a January decision to pause shipments of its Gardasil vaccine to China due to a downturn in demand.

Bloomberg on MSN · 1d

Merck Expects $200 Million Hit From Current US Tariffs

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China.

The Wall Street Journal on MSN · 1d

Merck Cuts 2025 Outlook on Tariffs, Charges

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.

pharmaphorum20h

Merck puts a price on its SpringWorks takeover bid

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...

Morningstar28d

Germany's Merck Teams Up With Abbisko for Global Sale Rights of Bone-Tumor Drug

Merck will partner with Chinese biotech Abbisko ... expanding its commercialization rights for the drug beyond Asia. The German pharmaceutical company said Friday that it would pay Abbisko an ...

Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally to Bring STEM Education to Students

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...

2don MSN

Morning Bid: Dour sentiment readings threaten relief rally

Europe's souring business sentiment looks likely to put stocks on the defensive on Thursday, as President Donald Trump's ...

Morningstar29d

Zebra Technologies and Merck KGaA, Darmstadt, Germany Collaborate to Create Safety and Traceability Solutions

This integration builds trust in AI systems regarding data authenticity and origin,” said Thomas Endress, Head of M-Trust™, Merck KGaA, Darmstadt, Germany. “Our collaboration with Zebra ...

Newsable Asianet News on MSN1d

SpringWorks Therapeutics Retail Chatter Spikes As Germany’s Merck Confirms Late-Stage Talks For $3.5B Buyout

Shares of SpringWorks Therapeutics Inc. ended over 9% higher on Thursday following a report that the company is inching ...

1don MSN

Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 million

Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results